# Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

> **NCT03515915** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 30 (estimated)

## Conditions studied

- Patients With Recurrent or Refractory Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03515915
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-23
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03515915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03515915, "Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03515915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*